HUP0002777A1 - Kondenzált tiazolo-benzo-heterociklusos származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Kondenzált tiazolo-benzo-heterociklusos származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0002777A1 HUP0002777A1 HU0002777A HUP0002777A HUP0002777A1 HU P0002777 A1 HUP0002777 A1 HU P0002777A1 HU 0002777 A HU0002777 A HU 0002777A HU P0002777 A HUP0002777 A HU P0002777A HU P0002777 A1 HUP0002777 A1 HU P0002777A1
- Authority
- HU
- Hungary
- Prior art keywords
- alk
- thiazolobenzoheterocyclic
- fused
- derivatives
- preparation
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical group [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 230000001773 anti-convulsant effect Effects 0.000 abstract 1
- 239000001961 anticonvulsive agent Substances 0.000 abstract 1
- 229960003965 antiepileptics Drugs 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000002431 hydrogen Chemical group 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052711 selenium Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 230000024587 synaptic transmission, glutamatergic Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D517/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms
- C07D517/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms in which the condensed system contains two hetero rings
- C07D517/06—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
A találmány tárgyát az, (I) általános képletű vegyületek - ahol R1kén- vagy szelénatom; R2 hidrogénatom vagy alkilcsoport; -R3-R4-R5-R6-= -CH2-CH2-CH2-CH2-, -CH2-CH2-CH2-CO-, -CH2-CH2-CH2-CH(R8)-,-H2-CH2-CH2-Se-, -CH2-CH2-Se-CH2-, -CH2-CH2-CH2-S-, -CH2-CH2-CH2-SO-, -CH2-CH2-CH2-SO2, -CH2-CH2-CH2-O-,-CH2-CH2-CH2-N(R9) , -CH2-CH2-CO-CH2-, -CH2-CH2-CH(R8)-CH2-,-CH2-CH2-S-CH2-, -CH2-CH2-SO-CH2-, -CH2-CH2-SO2-CH2-, -CH2-C (alk) (alk') -S-CH2-, -CH2-C (alk) (alk') -SO-CH2-, -CH2-C (alk) (alk') -SO2-CH2-, -CH2-CH (R10) -S-CH2-, -CH2-CH (R10) -SO-CH2-, -CH2-CH (R10) -SO2-CH2-, -CH2-CH2-O-CH2-, -CH2-CH2-N (R9) -CH2-vagy -CH2-CO-N (R9) -CH2- képletű csoport; R7 polifluor-alkil- vagypolifluor-alkoxi-csoport; R8 hidroxilcsoport; R9 hidrogénatom, alkil-vagy benzilcsoport; R10 alkil-, -CH2-OH, -COOalk, karboxil- vagykarbamoilcsoport; alk és alk' alkilcsoport - és izomerjeik,racemátjaik, enantiomerjeik, sóik, az előállításukra szolgáló eljárásés ezeket tartalmazó gyógyszerkészítmények képezik. A vegyületekgörcsoldó hatásúak, és a glutamaterg transzmissziót gátolják. Ó
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9709556A FR2766487B1 (fr) | 1997-07-28 | 1997-07-28 | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
| PCT/FR1998/001638 WO1999005147A1 (fr) | 1997-07-28 | 1998-07-24 | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0002777A1 true HUP0002777A1 (hu) | 2001-07-30 |
| HUP0002777A3 HUP0002777A3 (en) | 2002-12-28 |
| HU226210B1 HU226210B1 (en) | 2008-06-30 |
Family
ID=9509694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0002777A HU226210B1 (en) | 1997-07-28 | 1998-07-24 | Fused thiazolobenzoheterocyclic derivatives, process for their preparation and pharmaceutical compositions containing same |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6369221B1 (hu) |
| EP (1) | EP1000067B1 (hu) |
| JP (1) | JP4491131B2 (hu) |
| KR (1) | KR100621703B1 (hu) |
| CN (1) | CN1122670C (hu) |
| AT (1) | ATE226585T1 (hu) |
| AU (1) | AU746193B2 (hu) |
| BR (1) | BR9811056A (hu) |
| CA (1) | CA2298974C (hu) |
| CZ (2) | CZ2000194A3 (hu) |
| DE (1) | DE69808922T2 (hu) |
| DK (1) | DK1000067T3 (hu) |
| ES (1) | ES2187997T3 (hu) |
| FR (1) | FR2766487B1 (hu) |
| HU (1) | HU226210B1 (hu) |
| IL (4) | IL158356A0 (hu) |
| NO (1) | NO314630B1 (hu) |
| NZ (1) | NZ502054A (hu) |
| PL (1) | PL195758B1 (hu) |
| PT (1) | PT1000067E (hu) |
| RU (1) | RU2198889C2 (hu) |
| SK (1) | SK285767B6 (hu) |
| TW (1) | TW570923B (hu) |
| WO (1) | WO1999005147A1 (hu) |
| ZA (1) | ZA986680B (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0307067D0 (en) * | 2002-12-17 | 2003-04-30 | Aventis Pharma Inc | Use of thiazolobenzoheterocycles for treating multiple sclerosis |
| FR2863612B1 (fr) * | 2003-12-12 | 2006-03-03 | Aventis Pharma Sa | PROCEDE DE FABRICATION DE PRODUIT DE TYPE THIAZOLO[3,4,5-de] [4,1]BENZOTHIAZEPINE |
| US7179909B2 (en) | 2003-12-12 | 2007-02-20 | Aventis Pharma S.A. | Process for the manufacture of a product of the thiazolo [3,4,5-de] [4,1]benzothiazepine type |
| FR2867187B1 (fr) * | 2004-03-02 | 2007-10-12 | Centre Nat Rech Scient | Procede utile pour la preparation de benzazepines et derives de celles-ci. |
| SI3025586T1 (sl) * | 2013-07-22 | 2019-06-28 | Sumitomo Chemical Company Limited | Sestavek za obvladovanje rastlinskih bolezni in njegova uporaba |
| AU2014294144B2 (en) * | 2013-07-22 | 2017-06-01 | Sumitomo Chemical Company, Limited | Plant disease control composition and application for same |
| CA2918709C (en) | 2013-07-22 | 2021-07-13 | Sumitomo Chemical Company, Limited | Plant fungal disease control composition and its use |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1173701A (en) * | 1967-03-24 | 1969-12-10 | Smith Kline French Lab | 5-Substituted-1,4-Benzodiazepines |
| US3794646A (en) * | 1970-04-14 | 1974-02-26 | Robins Co Inc A H | 5,7-disubstituted-1,9-tetramethylene-1,4-benzodiazepin-2-ones |
| US3857854A (en) * | 1971-09-08 | 1974-12-31 | Upjohn Co | 6-phenyl-1h,4h-{8 1,2,4{9 oxadiazalo{8 4,3-2{9 {8 1,4{9 benzodiazepin-1-ones |
| US3850948A (en) * | 1973-07-27 | 1974-11-26 | Hoffmann La Roche | Certain 3a,4-dihydro-8-chloro-6-phenyl-thiazolo(3,2-h)-1,4-benzodiazepin-1(2h)-ones |
| US3962440A (en) * | 1973-12-26 | 1976-06-08 | Eli Lilly And Company | Quinoxaline compounds as hypnotic agents |
| US4107303A (en) * | 1976-06-24 | 1978-08-15 | E. I. Du Pont De Nemours And Company | Antihypertensive hexafluorohydroxyisopropyl benzazepines and benzazocines |
| US4218448A (en) * | 1976-06-24 | 1980-08-19 | E. I. Du Pont De Nemours And Company | Antihypertensive polyfluorohydroxyisopropyl bicyclic and tricyclic carbostyrils |
| DK160941C (da) * | 1988-06-28 | 1991-10-21 | Novo Nordisk As | Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar |
| US5248679A (en) * | 1988-09-09 | 1993-09-28 | Fujisawa Pharmaceutical Co., Ltd. | Tricyclic compounds |
| FR2649701B2 (fr) * | 1988-12-15 | 1991-11-22 | Rhone Poulenc Sante | Derives d'imino-2 benzothiazoline, leurs procedes de preparation et les medicaments les contenant |
| EP0705835A1 (de) * | 1994-09-01 | 1996-04-10 | Ciba-Geigy Ag | Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione |
-
1997
- 1997-07-28 FR FR9709556A patent/FR2766487B1/fr not_active Expired - Fee Related
-
1998
- 1998-07-02 CZ CZ2000194A patent/CZ2000194A3/cs unknown
- 1998-07-23 TW TW087112045A patent/TW570923B/zh not_active IP Right Cessation
- 1998-07-24 EP EP98940327A patent/EP1000067B1/fr not_active Expired - Lifetime
- 1998-07-24 RU RU2000104838/04A patent/RU2198889C2/ru not_active IP Right Cessation
- 1998-07-24 BR BR9811056-0A patent/BR9811056A/pt not_active IP Right Cessation
- 1998-07-24 CA CA002298974A patent/CA2298974C/fr not_active Expired - Fee Related
- 1998-07-24 CN CN98807624A patent/CN1122670C/zh not_active Expired - Fee Related
- 1998-07-24 HU HU0002777A patent/HU226210B1/hu not_active IP Right Cessation
- 1998-07-24 DE DE69808922T patent/DE69808922T2/de not_active Expired - Lifetime
- 1998-07-24 AT AT98940327T patent/ATE226585T1/de active
- 1998-07-24 NZ NZ502054A patent/NZ502054A/en not_active IP Right Cessation
- 1998-07-24 DK DK98940327T patent/DK1000067T3/da active
- 1998-07-24 PT PT98940327T patent/PT1000067E/pt unknown
- 1998-07-24 ES ES98940327T patent/ES2187997T3/es not_active Expired - Lifetime
- 1998-07-24 AU AU88676/98A patent/AU746193B2/en not_active Ceased
- 1998-07-24 CZ CZ2000294A patent/CZ289468B6/cs not_active IP Right Cessation
- 1998-07-24 JP JP2000504142A patent/JP4491131B2/ja not_active Expired - Fee Related
- 1998-07-24 IL IL15835698A patent/IL158356A0/xx active IP Right Grant
- 1998-07-24 PL PL98338348A patent/PL195758B1/pl not_active IP Right Cessation
- 1998-07-24 IL IL13419298A patent/IL134192A0/xx active IP Right Grant
- 1998-07-24 WO PCT/FR1998/001638 patent/WO1999005147A1/fr active IP Right Grant
- 1998-07-24 KR KR1020007000879A patent/KR100621703B1/ko not_active IP Right Cessation
- 1998-07-24 SK SK114-2000A patent/SK285767B6/sk not_active IP Right Cessation
- 1998-07-27 ZA ZA986680A patent/ZA986680B/xx unknown
-
2000
- 2000-01-18 US US09/484,836 patent/US6369221B1/en not_active Expired - Fee Related
- 2000-01-24 IL IL134192A patent/IL134192A/en not_active IP Right Cessation
- 2000-01-27 NO NO20000423A patent/NO314630B1/no not_active IP Right Cessation
-
2003
- 2003-10-09 IL IL158356A patent/IL158356A/en not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT77925A (hu) | Dihidrobenzofuránok, azokat tartalmazó gyógyászati készítmények és eljárás előállításukra | |
| AU8794291A (en) | New oxazolopyridine derivatives, processes for preparing these and pharmaceutical compositions containing them | |
| ES542320A0 (es) | Un procedimiento para la preparacion de derivados de la 2 pirimidinil 1 piperazina | |
| HUP9901074A2 (hu) | Tetrahidropirán és tetrahidrotiopirán aminosavak és ezeket tartalmazó gyógyszerkészítmények | |
| IL151172A0 (en) | Amine derivatives, their preparation and use as bax modulators | |
| ES2123652T3 (es) | 7-(2-aminoetil)-benzotiazolonas. | |
| TR200000148T2 (tr) | 1-(4-Karbazoliloksi)-3-(2-metoksifenoksi) etilamino)-2-propanol' ün modifikasyonu, gerekli proses ve farmasötik bileşimler. | |
| FI965074A0 (fi) | Tropaani-2-aldoksiinijohdannaisia hermoston välittäjäaineiden takaisinoton estäjinä | |
| NO20050664L (no) | 2,4 substituerte indoler og anvendelse derav som 5-HT6 modulatorer | |
| ES481128A1 (es) | Procedimiento para la preparacion de nuevos derivados fenil-piperazinicos. | |
| TR200101711T2 (tr) | Antihistaminik spiro bileşikler. | |
| HUP0002777A1 (hu) | Kondenzált tiazolo-benzo-heterociklusos származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| DK1034174T3 (da) | Azaringetherderivater og disses anvendelse som nikotin-ACh-receptormodulatorer | |
| IL113365A0 (en) | 5-heterocyclo-1,5-benzodiazepine derivatives, their preparation and use and pharmaceutical compositions containing them | |
| DK0902684T3 (da) | Hexahydro-pyrido (4,3-B) indolderivater som antipsykotiske lægemidler | |
| PT728138E (pt) | Derivados de antraciclina | |
| DK0452204T3 (da) | Hidtil ukendte 3-aminochromanderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| DE602004007181D1 (de) | 2,4,6-tris(4'aminobenzaldineopentylmalonat)-s-triazin, dieser enthaltenden Sonnenschutzzusammensetzungen und dessen Verwendungen | |
| MX9400165A (es) | Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen. | |
| HUP0004292A2 (hu) | (Fenil-alkil)-imidazol típusú H3-receptor ligandumok ezeket tartalmazó gyógyászati készítmények és alkalmazásuk | |
| HUP0001058A2 (hu) | 5-Hidroxi-metil-2-amino-tetralinok mint szív-érrendszerre ható szerek, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| NO973341L (no) | Anvendelse av 3,4-difenylkromaner til fremstilling av et farmasöytisk preparat for vasodilatorisk behandling eller profylakse | |
| ES2027492A6 (es) | Procedimiento de preparacion de nuevos derivados dihidropirimidotiazinos y de sus sales de adicion acidas farmaceuticamente aceptables. | |
| DK0765322T3 (da) | Indolderivater som pro-drugs for 5-HT1-lignende receptoragonister | |
| AU567498B2 (en) | 5-phenyl-1h-2,3-dihydro-1,4-benzodiazepine derivatives. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): BELICZAY LASZLO, S.B.G. & K. BUDAPESTI NEMZETKOEZI SZABADALMI IRODA, HU Representative=s name: RATHONYI ZOLTAN, S.B.G. & K. SZABADALMI UEGYVI, HU |
|
| FH92 | Termination of representative |
Representative=s name: BELICZAY LASZLO, S.B.G. & K. BUDAPESTI NEMZETK, HU |
|
| FH91 | Appointment of a representative |
Free format text: FORMER REPRESENTATIVE(S): RATHONYI ZOLTAN, S.B.G. & K. SZABADALMI UEGYVIVOEI IRODA, HU Representative=s name: DANUBIA SZABADALMI ES JOGI IRODA KFT., HU |
|
| FH92 | Termination of representative |
Representative=s name: RATHONYI ZOLTAN, S.B.G. & K. SZABADALMI UEGYVI, HU |
|
| MM4A | Lapse of definitive patent protection due to non-payment of fees |